\'\'

Breast Cancer Drug Approved By FDA

By on February 23, 2013

THE FOOD AND DRUG ADMINISTRATION HAS APPROVED A FIRST-OF-A-KIND BREAST CANCER MEDICATION THAT TARGETS TUMOR CELLS WHILE SPARING HEALTHY ONES.

 

THE DRUG KADCYLA FROM ROCHE COMBINES THE ESTABLISHED DRUG HERCEPTIN WITH A POWERFUL CHEMOTHERAPY DRUG AND A THIRD CHEMICAL LINKING THE MEDICINES TOGETHER. THE CHEMICAL KEEPS THE COCKTAIL INTACT UNTIL IT BINDS TO A CANCER CELL, DELIVERING A POTENT DOSE OF ANTI-TUMOR POISON. CANCER RESEARCHERS SAY THE DRUG IS AN IMPORTANT STEP FORWARD IN THE FIGHT AGAINST BREAST CANCER.